What is Ovarian Cancer

Ovarian cancer is a malignant ovarian neoplasm (an abnormal growth located on the ovaries). It is the fifth leading cause of cancer death in women, the leading cause of death from ...

Join Now

Free, anonymous support from people just like you.

Spread the Word!
Get a DS flyer to post
DS Store is Open
DS t-shirts and more
Discussion:
New Blood tests for screening
Watch this 
View More Posts Ignore
I wanted to post some exciting advances in the pursuit of markers (blood tests) that help us screen for ovarian cancer
As many of you know the CA-125 is normal in 30% of ovarian cancers and helps us if it is very high (over 200) but can be elevated for many other benign conditions....which is why routine screening with CA-125 can be tricky.

1) There is a gene that is OVEREXPRESSED in ovarian cancers called HE4 (human epidydmis protein 4)
2) HE4 is a blood test (currently being studied and not yet available) that has sensitivity similar to CA-125 BUT GREATER SPECIFICITY than CA-125 in diagnosing early ovarian cancers.

Dr O.
Posted on 06/13/07, 11:06 pm
RATE THIS POST:
Inspirational
Moving
Helpful
Creative
3 Replies Add Your Reply
Reminder: This is a support group for Ovarian Cancer. We trust you will do your best to remain positive and helpful. For more information, see our rules of the road.

You may also create your own Member Groups where you can moderate the discussion.
Comment:
Email me when others reply to this topic help
View More Posts Ignore
Reply #1 - 07/25/07  7:10pm
" Hi Orrange,

I hope you will look at my discussion on a screening test available that is 100% accurate in detecting ovarian cancer in clinical trials. This test has been available since 2002. It's called proteomics and I have been waiting since then because I am so high risk for ovarian cancer. Why is it not available? I did some research and the FDA is holding it up. They approve drugs that cause damage to the liver and death but this non-invasive test that only requires a drop of blood is being held up. There has been conflicts of interest at the NIH and the FDA and you guessed it it's all about the money. Check on the web. Use these key words. Correlogic, conflict of interest, NIH and FDA and you will read plenty. This technology can diagnose all kinds of cancer in it's early stage but think of all the money that would be lost by companies in the business of curing advanced cancer. "
RATE THIS REPLY:
Inspirational
Moving
Helpful
Creative
View More Posts Ignore
Reply #2 - 07/25/07  8:03pm
" Hey SharonHanson
I am not nearly as cynical as you about this.
Everyone in medicine is incredibly excited about the field of proteomics (the study of proteins..to be distinguished from genomics which is the study of genes) and tons and tons of money is being poured in to basic research using proteomics for detection/treatment/predicting prognosis of ALL cancers (colon, ovarian, etc)
Remember a lab test does NOT require FDA approval and even on Correlogics own website they report they are still waiting to publish results from any long term prospective studies on ovacheck (the test you are talking about.)
It will be very very expensive for patients and I think we ALL want to make sure it works..the 100% accuracy you quote has not been tested in large trials (they tell you this on their own website) but wont that be great if that proves to be true....
Dr O. "
RATE THIS REPLY:
Inspirational
Moving
Helpful
Creative
View More Posts Ignore
Reply #3 - 07/27/07  9:17am
" Hello Dr. Orrange,

I don't believe I am cynical just honest. I have to respectfully disagree with you as I have reviewed their website and read numerous articles regarding this. You have to understand I have been waiting five years for this test to become commercially available and you can say all you want but five years for whatever reason is a long time to wait for a non-invasive test that only requires a drop of blood.
The FDA in a departure from previous practice decided to exercise regulatory authority in this area. It could be offered as a laboratory developed test, regulated under the Clinical Laboratory Improvement Act however because they decided to exercise regulatory authority over In Vitro Diagnostic Multivariate Index Assays it will require large-scale prospective clinical trials and many months of additional sample/data collection. I still ask why? A drop of blood is pretty non-invasive and I want to know why and I think others should also ask why and call their representatives to find out why the FDA has decided to do this. Lives could be saved. "
RATE THIS REPLY:
Inspirational
Moving
Helpful
Creative

You might also like ...

recent topics

By madona No comments

Detecting Recurrence: What Tests Are Best? Ovarian cancer recurrence is possible even after treatment for early stage …

After Chemo Follow-ups

By dananiehaus 3 Replies

I have been ovarian cancer free since 8/4/06. I go to my doctor every three months for a pelvic exam and a CA-125 and I …

Ovarian CA and screening??

By DrOrrange 21 Replies

I am asked by many of my patients about screening for ovarian cancer...Im going to post a discussion and hope others …

Content on DailyStrength.org is for informational purposes only. We do not provide any medical advice, diagnosis or treatment. More info
Portions of support group and treatment information provided by Wikipedia under the GNU FDL license
Copyright 2008 DailyStrength, Inc. All rights reserved. Terms of Service | Privacy Policy | Report Abuse | HSW International